PGRMC1 promotes triple-negative breast cancer cell growth via suppressing ferroptosis
Authors:
- 1 February 2023
- journal article
- research article
- Published by Taylor & Francis in Climacteric
- Vol. 26 (2) , 135-142
Abstract
Triple-negative breast cancer (TNBC) is the most malignant form of breast cancer with increasing incidence and mortality worldwide. The progesterone receptor membrane component-1 (PGRMC1) is a well...Keywords
Funding Information
- Scientific Research Common Program of Beijing Municipal Commission of Education (KM202010025009)
- Beijing Hospitals Authority Youth Programme (QML20181401)
- National Natural Science Foundation of China (81671411)
- Beijing Natural Science Foundation (7162062)
This publication has 29 references indexed in Scilit:
- Progesterone receptor membrane component 1 is phosphorylated upon progestin treatment in breast cancer cellsOncotarget, 2017
- The presence of a membrane-bound progesterone receptor induces growth of breast cancer with norethisterone but not with progesterone: A xenograft modelMaturitas, 2017
- Progesterone suppresses triple-negative breast cancer growth and metastasis to the brain via membrane progesterone receptor αInternational Journal of Molecular Medicine, 2017
- Molecular alterations in triple-negative breast cancer—the road to new treatment strategiesThe Lancet, 2017
- The evolutionary appearance of signaling motifs in PGRMC1BioScience Trends, 2017
- The emerging role of progesterone receptor membrane component 1 (PGRMC1) in cancer biologyBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2016
- Haem-dependent dimerization of PGRMC1/Sigma-2 receptor facilitates cancer proliferation and chemoresistanceNature Communications, 2016
- Progesterone receptor membrane component 1 promotes survival of human breast cancer cells and the growth of xenograft tumorsCancer Biology & Therapy, 2016
- Protein kinase CK2 in breast cancer: the CK2β regulatory subunit takes center stage in epithelial plasticityCellular and Molecular Life Sciences, 2015
- Protein kinase CK2 modulates IL-6 expression in inflammatory breast cancerBiochemical and Biophysical Research Communications, 2011